STOCK TITAN

Editas Medicine to Host Conference Call Discussing Third Quarter 2021 Results and Corporate Update

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Editas Medicine, a leader in genome editing, will host a conference call on November 8, 2021, at 8:00 a.m. ET. The call will provide a corporate update and third-quarter results for 2021. U.S. participants can join by calling 877-407-0989, while international callers can dial 201-389-0921. A live webcast will also be available on the Editas Medicine website. Editas focuses on developing CRISPR/Cas9 and CRISPR/Cas12a technologies to create precise genomic medicines for serious diseases globally.

Positive
  • None.
Negative
  • None.

CAMBRIDGE, Mass., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that it will host a conference call and webcast on Monday, November 8, 2021, at 8:00 a.m. ET to provide a corporate update and results for the third quarter of 2021.

To access the conference call:

  • U.S. callers should dial 877-407-0989 and international callers should dial 201-389-0921 approximately five minutes before the call begins.
  • Participants should ask to be connected to the Editas Medicine earnings conference call.

A live webcast and replay of the conference call can also be accessed in the Investors section of the Editas Medicine website at https://www.editasmedicine.com/.

About Editas Medicine
As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a (also known as Cpf1) genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. For the latest information and scientific presentations, please visit www.editasmedicine.com.

Contacts:
Media
Cristi Barnett
(617) 401-0113
cristi.barnett@editasmed.com 

Investors
Ron Moldaver
(617) 401-9052
ir@editasmed.com 


FAQ

What is the date of Editas Medicine's upcoming conference call?

The conference call for Editas Medicine is scheduled for November 8, 2021.

What time will the Editas Medicine conference call start?

The conference call will start at 8:00 a.m. ET.

How can I access the Editas Medicine conference call?

You can access the call by dialing 877-407-0989 for U.S. callers and 201-389-0921 for international callers.

Where can I find the webcast for Editas Medicine's conference call?

The live webcast will be available in the Investors section of the Editas Medicine website.

What topics will be discussed in the Editas Medicine conference call?

The call will cover a corporate update and the third-quarter results for 2021.

Editas Medicine, Inc.

NASDAQ:EDIT

EDIT Rankings

EDIT Latest News

EDIT Stock Data

110.61M
82.28M
0.32%
71.08%
19.27%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
CAMBRIDGE